|
FBXO45 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.60710000000664E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.51160000000062E-05 |
| Normal-vs-Stage2 |
6.456100E-02 |
| Normal-vs-Stage3 |
5.144500E-03 |
| Normal-vs-Stage4 |
1.001640E-03 |
| Stage1-vs-Stage2 |
5.965600E-01 |
| Stage1-vs-Stage3 |
5.084800E-01 |
| Stage1-vs-Stage4 |
6.867200E-01 |
| Stage2-vs-Stage3 |
9.051800E-01 |
| Stage2-vs-Stage4 |
4.630000E-01 |
| Stage3-vs-Stage4 |
4.115600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.75320000000068E-05 |
| Normal-vs-AfricanAmerican |
2.290000E-01 |
| Normal-vs-Asian |
7.188000E-02 |
| Caucasian-vs-AfricanAmerican |
2.063800E-02 |
| Caucasian-vs-Asian |
7.702600E-01 |
| AfricanAmerican-vs-Asian |
2.340200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.559200E-04 |
| Normal-vs-Female |
8.08680000000672E-05 |
| Male-vs-Female |
4.341400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.819800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.181300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.624700E-04 |
| Normal-vs-Age(81-100Yrs) |
3.240200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.147000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.254600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.081400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.201600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.795000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.781200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.142000E-02 |
| Normal-vs-Grade 2 |
1.54961999999648E-05 |
| Normal-vs-Grade 3 |
1.476180E-02 |
| Normal-vs-Grade 4 |
5.937500E-03 |
| Grade 1-vs-Grade 2 |
5.379600E-01 |
| Grade 1-vs-Grade 3 |
2.900400E-01 |
| Grade 1-vs-Grade 4 |
5.510000E-01 |
| Grade 2-vs-Grade 3 |
1.456040E-02 |
| Grade 2-vs-Grade 4 |
7.812600E-01 |
| Grade 3-vs-Grade 4 |
2.448200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.67750000004785E-06 |
| Normal-vs-ccB subtype |
1.820320E-03 |
| ccA subtype-vs-ccB subtype |
2.023200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.162600E-04 |
| Normal-vs-N1 |
4.071800E-02 |
| N0-vs-N1 |
2.609600E-01 |
|
|
